La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Equillium a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Equillium..

Equillium (NASDAQ:EQ) Azioni, Catena delle Opzioni

Equillium

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Equillium Inc

Equinox Gold Corp

EQT Corp

Equitable Holdings Inc

Equinor ASA

Equity Residential Common Shares of Beneficial Interest

Equity Residential

EQUITY METALS CORPORATION by Equity Metals Corporation

Equity Metals Corp

Equinix Inc

EQ Labs Inc

ALTAMIRE GOLD CORP ORD by Altamira Gold Corp

Altamira Gold Corp

ALPS Equal Sector Weight ETF

Equity Bancshares, Inc. Class A Common Stock

Equity Bancshares Inc

EQV Ventures Acquisition Corp. Class A Ordinary Shares

EQV Ventures Acquisition Corp

Invesco S&P 100 Equal Weight ETF

Equitable Holdings, Inc. Depositary Shares

Valued Advisers Trust Kovitz Core Equity ETF

Invesco Russell 1000 Equal Weight ETF

Columbia U.S. Equity Income ETF

Equitable Holdings, Inc. Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series C

EQV Ventures Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

Equus Total Return Inc

EQUITABLE FINCL CORP by Equitable Financial Corp.

Equitable Financial Corp

EQV Ventures Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant

iShares Trust iShares MSCI Emerging Markets Quality Factor ETF

ProShares Equities for Rising Rates ETF

DISA Ltd

EQT AB

MENSA MINING CORP by Mensa Mining Corp.

EQB Inc

EQUINITI GROUP PLC ADR by Equiniti Group PLC

Invesco S&P 500 Equal Weight Index ETF

Invesco S&P 500 Equal Weight Index ETF (CAD Hedged)

EQUINOX RES LTD by EQUINOX RES LTD

Eqonex Ltd Ordinary Shares

EQRX INC WT EXP

EQS GROUP AG by EQS GROUP AG

Equal Trading Inc

EQM Technologies & Energy Inc Com

EQUITECH INTL CORP by Equitech Int'l Corp.

Equitech International Corp

Lake Winn Resources Corp

LAKE WINN RESOURCES CORP by Lake Winn Resources Corp

QuadrantProtocol

EQUATORIAL ENERGIA S/ADR by Equatorial Energia S.A.

Equatorial SA

EQUATORIAL RES LTD ORD by Equatorial Resources Ltd.

Equatorial Resources Ltd

Equalizer

Press Releases

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Equillium Announces Feedback from the U.S. Food and Drug Administration

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists

Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy

Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic

News

Wall Street Eyes: EQ, PRSO, WLGS, ENTO, GIBO Stocks Lead Sub-$1 Surge

Equillium to Participate in the Cantor Global Healthcare Conference 2025

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Health Care

NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor

ENTO

GIBO

PRSO

WLGS

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Celularity

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Cue Biopharma

Dyadic International, Inc. - Common Stock

Dyadic International

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroGen

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

ImmuCell

INmune Bio

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

MAIA Biotechnology

Medicus Pharma

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

RenovoRx

Serina Therapeutics

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

Comments

Equillium

Equillium (EQ) Opzioni

Equillium (NASDAQ:EQ) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO